SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense momentum fueled by a fresh defense contract and broader investor interest in memory hardware for AI and data centers. The community is actively debating the potential for a short squeeze, balancing excitement over the company's patented technology and military-grade applications against concerns regarding high valuations and pending legal issues.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative momentum as investors rotate back into Japanese blockchain projects and IoT-focused assets. While community sentiment remains polarized between long-term holders citing ecosystem expansion and skeptics highlighting a lack of official partnership news, traders are closely monitoring technical breakouts and exchange accumulation trends.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is trending as the community closely monitors the potential Senate markup of the Clarity Act, which many believe could provide the regulatory framework necessary to unlock institutional capital. While some investors remain frustrated by recent price consolidation, others are actively tracking increased ETF inflows and new integration partnerships as signals that structural adoption is building for the long term.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the FDA moves to block compounded versions of popular GLP-1 weight-loss drugs, a significant catalyst that strengthens the brand dominance of official products like Wegovy and Ozempic. The community is actively discussing this regulatory shift, with many investors anticipating that the reduced competition will accelerate adoption, boost market share, and act as a tailwind heading into the upcoming earnings report.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are actively debating the future of CRO, with community sentiment split between frustration over persistent token dilution and optimism regarding potential ETF filings and mobile app developments. While some participants are aggressively accumulating, others remain wary, highlighting concerns over management transparency and historical underperformance relative to broader market gains.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is attracting significant community attention as it transitions toward a sovereign cloud infrastructure model, with active discussions focusing on its potential to offer an alternative to centralized Big Tech providers like AWS. While investors are debating the long-term impact of deflationary tokenomics and network activity, the community is closely monitoring institutional interest and technical development milestones as catalysts for potential momentum.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following a corporate update regarding financial results and the company's progress toward a pivotal Phase 3 clinical trial for its lead candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some community members are optimistic about the upcoming trial registration path and orphan drug designations, others are expressing skepticism, focusing on potential share dilution and concerns over aggressive social media promotion.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending as community members aggressively debate its long-term potential as a high-speed institutional settlement layer, often citing its reported partnership history and infrastructure capabilities. The discussion is heavily polarized between bullish investors highlighting its 11M TPS architecture and potential fintech use cases versus skeptics who dismiss the activity as repetitive spam or an unproven pump-and-dump scheme.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is seeing active community discussion as investors debate its long-term enterprise utility versus ongoing concerns regarding token dilution and price performance. While some participants are accumulating positions in anticipation of future institutional adoption and network upgrades, others are skeptical, focusing on the heavy token supply and historical price volatility.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending as investors debate the impact of the newly launched spot ETF against a backdrop of broader market volatility and institutional interest in RWA tokenization. Community sentiment is deeply polarized, with many users expressing frustration over recent price declines while long-term holders actively accumulate positions in anticipation of a potential bull cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The partnership makes Medirom the operator for World ID verification across Japan.</li><li>Its rollout will use Medirom’s 300 locations, along with flagship and pop-up sites, to scale quickly.</li><li>Investors reacted positively to the prospect of a new, recurring revenue stream beyond wellness.</li></ul>Shares of Medirom Healthcare Technologies Inc. (MRM) jumped about 10% in after-hours trading on Friday after the company announced a partnership tied to OpenAI CEO Sam Altman’s World project, positioning Medirom as a key operator in Japan’s rollout of “Proof of Human” verification technology.<h2 class="st-heading-2">Medirom Picked To Operate World ID Locations In Japan</h2>Medirom said it has entered into a master service agreement with Tools for Humanity and the World Foundation to operate World’s “Proof of Human” verification locations across Japan. World is a biometric identity project co-created by Sam Altman and Alex Blania that aims to help users prove they are human online without revealing personal identity.Under the agreement, Medirom will be responsible for running verification sites using World’s technology, including the deployment of Orb devices that confirm humanness through privacy-preserving biometric methods.<h2 class="st-heading-2">Nationwide Rollout&nbsp;</h2>Medirom plans to use its nationwide footprint of roughly 300 locations to accelerate deployment. The company said it will also establish flagship verification sites and temporary pop-up locations in commercial and public spaces, supported by a newly formed internal task force dedicated to the project.The company expects the initiative to generate revenue over time through operating fees and related services as adoption scales.<h2 class="st-heading-2">‘Proof of Human’ Gains Focus Amid AI Boom</h2><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/sam-altman-world-eye-scanning-startup-uk/chlEkYsRby1">World project was created</a> to address growing concerns that advances in AI are making it harder to distinguish humans from bots online. The project uses blockchain-based infrastructure to provide users with an anonymous World ID that can be used across participating platforms.Tools for Humanity, which led the initial development of the World project, said Japan’s high level of technology adoption makes it a key market for expanding digital identity infrastructure.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Medirom was ‘extremely bullish’ amid ‘high’ message volume.<figure class="image"><img style="aspect-ratio:974/141;" src="https://news.stocktwits-cdn.com/mrm_ss_png_f13ca655da.webp" alt="mrm ss.png" width="974" height="141"><figcaption>MRM sentiment and message volume as of December 26| Source: Stocktwits</figcaption></figure>One user said they can see the stock “rallying” next week.<stembedurl>https://stocktwits.com/squarellim/message/640209408</stembedurl><a href="https://stocktwits.com/symbol/MRM">Medirom’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the MEDIROM Healthcare Technologies logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Medirom Stock Jumps 10% After Hours On Deal To Run Sam Altman’s World ‘Proof Of Human’ Sites In Japan

The deal positions Medirom at the center of Japan’s push to deploy human-verification infrastructure as AI adoption accelerates.

Equity

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 2.8% Higher - Here's Why

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 2.8% Higher - Here's Why...

MEDIROM Healthcare Technologies (NYSE:MRM) Stock Price Up 1% - Should You Buy?

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 1% Higher - Here's Why...

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 1.6% Higher - What's Next?

MEDIROM Healthcare Technologies (NYSE:MRM) Trading Up 1.6% - Should You Buy...

Shares of Medirom Healthcare Technologies surged over 250% in premarket trading on Friday after the Tokyo-based wellness and healthtech company announced a partnership with World, the “proof of human” protocol co-founded by OpenAI’s Sam Altman and Alex Blania of Tools for Humanity.Medirom said it will install World ID’s Orb authentication devices across 100 of its Re.Ra.Ku relaxation studios in Japan this month, expanding to 200 locations nationwide. The rollout represents the largest Orb deployment in Japan so far, aimed at providing broad access to a system that verifies individuals’ “humanness” without revealing their identity.The Orb, an advanced imaging device, issues a World ID once verification is complete, which is stored in the World App for use across compatible services. Medirom said its integration of the devices underscores its push to fuse healthcare with technology while accelerating World ID adoption in Japan.The company operates over 300 wellness salons under various brands, including Re.Ra.Ku, Spa Re.Ra.Ku, and Bell Epoc, and also develops digital health solutions, including the Lav training app and the Mother Bracelet, a battery-free smart tracker used in industries from caregiving to construction.On Stocktwits, retail sentiment for Medirom was ‘extremely bullish’ amid ‘extremely high’ message volume.Some retail traders speculated on sharp price targets for Medirom, with one suggesting the stock could open at around $7, while another said it might climb to $10 during the session.<stembedurl>https://stocktwits.com/madstocks123/message/630074517</stembedurl><stembedurl>https://stocktwits.com/HellenicRenegade/message/630087145</stembedurl><a href="https://stocktwits.com/symbol/MRM">Medirom’s stock</a> has risen nearly 41% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is Medirom Healthcare Technologies Stock Surging Over 250% Premarket Today?

The surge followed news that Medirom will deploy Sam Altman’s World ID Orb devices across its Re.Ra.Ku studios in Japan.

Medirom Healthcare Technologies ($MRM) ADR shares were down 12% on Monday, even as the Japan-based wellness salon operator announced a series A equity raise by its subsidiary.Medirom subsidiary Medirom Mother Labs Inc. has raised an aggregate total of 260.3 million yen, or about $1.7 million, at a pre-money equity valuation of JPY9 billion, or about $58.6 million in its Series A equity financing, the company said in a statement.The firm noted NFES Technologies Inc. was the lead investor in the financing round, along with several other public companies in Japan, including M3 Inc. and Elematec Corp. Certain individual investors also participated in the round. Medirom Mother Labs has closed financings with six investors to date and hopes to complete this round by December 31.“We are very excited that our Medirom Mother Labs subsidiary has received such significant validation from strategic partners as our lead investor NFES Technologies Inc.,” Kouji Eguchi, Medirom’s CEO, said in a statement. “The pre-money valuation of 9 billion yen is approximately multiples of Medirom’s current NASDAQ listing market capitalization…further validates our technology, business model, and growth potential.” Retail chatter on Stocktwits indicated a mixed take on the stock.<stembedurl>https://stocktwits.com/HumbleTrader187/message/596459081</stembedurl><stembedurl>https://stocktwits.com/biff1/message/596382806</stembedurl><stembedurl>https://stocktwits.com/Z_interceptor/message/596439765</stembedurl>Medirom operates over 300 wellness salons across Japan under its Re.Ra.Ku brand.Shares of the firm are down 80% year-to-date.(Calculations based on an exchange rate of JPY153.64 to $1)For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medirom Healthcare Stock Dips On Series A Equity Raise: Retail’s Divided

 NFES Technologies Inc. is the lead investor in the latest financing round.

MEDIROM Healthcare Technologies, Inc. owns, develops, operates, manages, and supports relaxation salons through the franchising and direct ownership of such salons. It provides relaxation and bodywork services. The firm operates two synergistic lines of businesses: Relaxation Salon Segment (retail) and Digital Preventative Healthcare Segment (healthtech). The company was founded by Kouji Eguchi on July 13, 2000 and is headquartered in Tokyo, Japan.

MEDIROM Healthcare Technologies Inc - ADR

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$1.12
Prev Close	$1.16
Open	$1.16
Dividend Yield	0.00%
50-Day Moving Average	$1.20
Beta	0.68
Avg. Volume	23,800.14
PE Ratio	3.06

52-Week High	$4.45
52-Week Low	$0.7221
Market Capitalization	$8.85M
EPS (Annual)	$0.0474
Price to Book	5.27
Revenue Per Employee	N/A

MRM
MEDIROM Healthcare Technologies Inc - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest MRM News

MRMMEDIROM Healthcare Technologies Inc - ADR